Global Bio-chem Technology Group Company Limited (stock code: 00809) issued a monthly return on movements in securities for the period ended 31 January 2026. According to the announcement, the total authorised share capital remained at HKD6,000,000,000, consisting of 30,000,000,000 ordinary shares and 30,000,000,000 convertible preference shares, both with a par value of HKD0.1 each.

As of 31 January 2026, the issued share capital for ordinary shares remained at 16,832,771,527 shares, of which 44,560,000 were treasury shares. The preference shares in issue stood at 17,267,750,569. There were no increases or decreases reported during the month. The announcement also indicated that the applicable public float requirement of 25% has been met. No other share issuance details were recorded.